Stonepine Capital Management as of Dec. 31, 2023
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 16 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Evolus (EOLS) | 24.3 | $56M | 5.3M | 10.53 | |
| Adma Biologics (ADMA) | 18.0 | $42M | 9.2M | 4.52 | |
| Amylyx Pharmaceuticals (AMLX) | 15.9 | $37M | 2.5M | 14.72 | |
| Quidel Corp (QDEL) | 14.3 | $33M | 450k | 73.70 | |
| Alimera Sciences Com New | 7.5 | $17M | 4.0M | 4.32 | |
| Xeris Pharmaceuticals (XERS) | 6.0 | $14M | 5.9M | 2.35 | |
| Galapagos Nv- Spons Adr (GLPG) | 4.6 | $11M | 262k | 40.65 | |
| Xoma Corp Com New (XOMA) | 2.0 | $4.6M | 250k | 18.50 | |
| Io Biotech (IOBT) | 1.4 | $3.1M | 1.7M | 1.88 | |
| Scynexis Com New (SCYX) | 1.3 | $3.0M | 1.4M | 2.23 | |
| Rezolute Com New (RZLT) | 1.2 | $2.7M | 2.8M | 0.99 | |
| Atea Pharmaceuticals (AVIR) | 1.1 | $2.6M | 840k | 3.05 | |
| Tela Bio (TELA) | 0.9 | $2.1M | 318k | 6.62 | |
| Aytu Biopharma (AYTU) | 0.6 | $1.3M | 473k | 2.84 | |
| Exagen (XGN) | 0.6 | $1.3M | 670k | 1.99 | |
| Atyr Pharma Com New (ATYR) | 0.3 | $680k | 482k | 1.41 |
